Back to Massachusetts

H1222 • 2025

An Act relative to prescription medication re-authorization

An Act relative to prescription medication re-authorization

Active

The official status still shows this bill as active or still awaiting another formal step.

Sponsor
Sally P. Kerans
Last action
2026-03-19
Official status
Referred to Joint Committee on Health Care Financing
Effective date
Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

An Act relative to prescription medication re-authorization

An Act relative to prescription medication re-authorization By Representative Kerans of Danvers, a petition (accompanied by bill, House, No.

What This Bill Does

  • An Act relative to prescription medication re-authorization By Representative Kerans of Danvers, a petition (accompanied by bill, House, No.
  • 1222) of Sally P.
  • Kerans relative to prohibiting insurers from requiring annual re-authorizations for certain prescription drugs.
  • Financial Services.

Limits and Unknowns

  • This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Bill History

  1. 2026-03-19 House

    Reporting date extended to Monday, June 15, 2026

  2. 2025-12-08 House

    Reporting date extended to Wednesday, March 18, 2026

  3. 2025-09-18 House

    Reported favorably by committee and referred to the committee on Health Care Financing

  4. 2025-06-03 Joint

    Hearing scheduled for 06/10/2025 from 10:30 AM-01:00 PM in A-2

  5. 2025-02-27 House

    Referred to the committee on Financial Services

  6. 2025-02-27 Senate

    Senate concurred

Official Summary Text

An Act relative to prescription medication re-authorization
By Representative Kerans of Danvers, a petition (accompanied by bill, House, No. 1222) of Sally P. Kerans relative to prohibiting insurers from requiring annual re-authorizations for certain prescription drugs. Financial Services.
Status:
Referred to Joint Committee on Health Care Financing

Current Bill Text

Read the full stored bill text
×

Bill H.1222

Notwithstanding any general or special law to the contrary, any licensed health insurer subject to the provisions of chapters 32A, 118E, 175, 176A, 176B or 176G of the General Laws shall not request or require annual re-authorizations for any prescription drug as defined in section 1 of chapter 94C of the General Laws that has been duly prescribed by a physician, physician’s assistant or nurse practitioner to treat any chronic disease including, but not limited to, diabetes, heart disease, Alzheimer's disease, cancer, stroke and respiratory disease

The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.

Close